Doxycycline — Class III drug recall D-1031-2016
Terminated recall by Galderma Laboratories, L.P., reported 2016-06-22, distributed nationwide. Labeling: Incorrect Or Missing Lot and/or Exp Date: Some expiries and lot numbers are missing.
| Recall number | D-1031-2016 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Galderma Laboratories, L.P., Fort Worth, TX, United States |
| Recall initiated | 2016-05-19 |
| Classified | 2016-06-14 |
| Reported by FDA | 2016-06-22 |
| Terminated | 2016-12-23 |
| Distributed | Nationwide (US) |
| Quantity | 71,340 bottles |
| Reason classes | labeling |
| NDC | 66993-0815-30 |
| Lot numbers | 1496059A, AD9848A |
| Expiration dates | 2017-08-31, 2017-11-30 |
Product
Doxycycline, USP Capsules 40 mg, Packaged in 30 ct Bottles, Rx Only. Marketed by: Prasco Laboratories, Mason, OH 45040 USA, Manufactured by: Catalent Pharma Solutions, LLC, Winchester, Kentucky 40391. NDC: 66993-815-30.
Reason for recall
Labeling: Incorrect Or Missing Lot and/or Exp Date: Some expiries and lot numbers are missing.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1031-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.